ACGT participates in cell and gene therapy panel discussions at the World Medical Innovation Forum on May 19 – 21, 2021

May 12, 2021

We are pleased to announce Alliance for Cancer Gene Therapy’s participation in the upcoming Mass General Brigham’s World Medical Innovation Forum, Gene and Cell Therapy 2021 & 2022.

Please join Alliance for Cancer Gene Therapy’s Chief Program Officer, Barbara Lavery, and Scientific Advisory Council Member, Nino Chiocca, MD, PhD, on May 19th for in-depth panel discussions about the grand challenges and potential patient benefits of gene and cell therapy.

About the World Medical Innovation Forum

The World Medical Innovation Forum, hosted by Mass General Brigham, is a global gathering of more than 1,700 senior health care leaders. It responds to the intensifying transformation of healthcare and its impact on innovation. The Forum is rooted in the belief that no matter the magnitude of that change, the center of health care needs to be a shared, fundamental commitment to collaborative innovation – industry and academia working together to improve patient lives.

The 2021 World Medical Innovation Forum will bring together global leaders in the emerging discipline of gene and cell therapy for in-depth conversations on the fast-developing novel technologies that characterize this early era of adoption. Impact on patients, clinicians and systems will be examined in depth. The Forum panels, consisting of industry and investment executives, teamed with Harvard clinical and research leaders, will focus on patient interactions across care settings, and the role technology and data can play in advancing knowledge discovery and care delivery.

Register at